Literature DB >> 8059694

Coronary artery disease and coronary artery bypass grafting in diabetic patients aged > or = 65 years (report from the Coronary Artery Surgery Study [CASS] Registry).

J I Barzilay1, R A Kronmal, V Bittner, E Eaker, C Evans, E D Foster.   

Abstract

A cohort of 317 diabetic patients, aged > or = 65 years, with angiographically proven coronary artery disease, was analyzed and followed for a mean of 12.8 years. Compared with 1,843 age-matched nondiabetic patients, diabetic patients were more likely to (1) have a higher number of coronary occlusions, (2) not be current smokers, (3) have higher systolic but lower diastolic blood pressures, (4) have evidence of peripheral vascular disease, and (5) be women. They did not differ significantly with respect to total cholesterol, family history of coronary artery disease, history of hypertension, or left ventricular hypertrophy. In the total elderly cohort, diabetes was found to be an independent predictor of mortality, conferring a 57.0% increased risk of death. Survival analysis showed that diabetic subjects consistently had higher mortality than nondiabetics. However, the relative survival benefit of coronary artery bypass graft surgery versus medical therapy was comparable in diabetic and nondiabetic patients. Surgical therapy conferred a reduction in mortality of 44%.

Entities:  

Mesh:

Year:  1994        PMID: 8059694     DOI: 10.1016/0002-9149(94)90399-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

Review 1.  Revascularization strategies in patients with diabetes: evolving concepts.

Authors:  J J Brennan; H S Cabin
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

2.  Is diabetes mellitus a major risk factor in coronary artery bypass grafting? The influence of internal thoracic artery grafting on late survival in diabetic patients.

Authors:  T Yamamoto; Y Hosoda; K Takazawa; I Hayashi; H Miyagawa; S Sasaguri
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-06

3.  Long-term benefits of internal thoracic artery-coronary artery bypass in Japanese patients.

Authors:  S Kitamura; K Kawachi; S Taniguchi; T Kawata; S Kobayashi; H Nishioka; K Mizuguchi; K Niwaya; Y Kameda; H Sakaguchi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-01

4.  Coronary revascularization in diabetic patients: Current state of evidence.

Authors:  Mukesh Singh; Rohit Arora; Vamsi Kodumuri; Sandeep Khosla; Evyan Jawad
Journal:  Exp Clin Cardiol       Date:  2011

5.  Coronary artery bypass grafting in diabetics: A growing health care cost crisis.

Authors:  Sajjad Raza; Joseph F Sabik; Ponnuthurai Ainkaran; Eugene H Blackstone
Journal:  J Thorac Cardiovasc Surg       Date:  2015-04-01       Impact factor: 5.209

6.  Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats.

Authors:  Samson Mathews Samuel; Mahesh Thirunavukkarasu; Suresh Varma Penumathsa; Srikanth Koneru; Lijun Zhan; Gautam Maulik; Perumana R Sudhakaran; Nilanjana Maulik
Journal:  Circulation       Date:  2010-03-01       Impact factor: 29.690

7.  Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

Authors:  A Rivard; M Silver; D Chen; M Kearney; M Magner; B Annex; K Peters; J M Isner
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

Review 8.  Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies.

Authors:  Christina Voulgari; Dimitrios Papadogiannis; Nicholas Tentolouris
Journal:  Vasc Health Risk Manag       Date:  2010-10-21

Review 9.  Stress echocardiogaphy: a useful test for assessing cardiac risk in diabetes.

Authors:  Rajan Sharma; Denis Pellerin
Journal:  Vasc Health Risk Manag       Date:  2009-04-08

10.  Aberrant angiogenesis: The gateway to diabetic complications.

Authors:  Sunil K Kota; Lalit K Meher; Sruti Jammula; Siva K Kota; S V S Krishna; Kirtikumar D Modi
Journal:  Indian J Endocrinol Metab       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.